NURS 6521 ADVANCED PHARMACOLOGY (ADV. PHARMACOLOGY)
COMPREHENSIVE EXAM PRACTICE & ACTUAL STUDY GUIDE — 2026/2027
LATEST UPDATE | 120+ PRACTICE QUESTIONS, VERIFIED SOLUTIONS WITH
RATIONALES
TABLE OF CONTENTS
i. Pharmacokinetics, Pharmacodynamics, and Drug Interactions
ii. Cardiovascular and Renal Pharmacotherapy
iii. Endocrine and Metabolic Pharmacology
iv. Antimicrobial and Antiviral Therapy
v. Central Nervous System and Psychiatric Pharmacology
vi. Respiratory and Gastrointestinal Pharmacology
vii. Hematologic, Oncologic, and Immunologic Pharmacology
viii. Pain, Inflammation, and Rheumatologic Therapy
ix. Special Populations, Safety, Monitoring, and Medication Management
INTRODUCTION
This advanced NURS 6521 pharmacology practice exam focuses on graduate-level
application of pharmacokinetics, pharmacodynamics, therapeutic drug monitoring,
adverse effects, drug interactions, contraindications, antimicrobial therapy,
cardiovascular medications, endocrine agents, psychiatric drugs, analgesics, and
pharmacotherapy in special populations. Questions emphasize clinical reasoning
rather than simple recall, requiring interpretation of patient findings, laboratory
values, medication profiles, and therapeutic priorities. Students should expect
challenging scenarios involving adverse drug reactions, renal and hepatic
considerations, polypharmacy, medication selection, monitoring parameters, and
patient-specific risk factors. The questions are designed to reinforce the level of
clinical judgment expected in advanced nursing pharmacology coursework and
professional practice.
QUESTION 1
A 72-year-old patient with atrial fibrillation and chronic kidney disease is prescribed
a medication that is primarily eliminated through the kidneys. The patient's serum
,creatinine increases substantially after an episode of dehydration. Which
pharmacokinetic consequence is most likely?
A. Increased hepatic first-pass metabolism
B. Decreased drug clearance and prolonged half-life
C. Increased volume of distribution caused by reduced renal perfusion
D. Decreased plasma protein binding caused by dehydration
🔴 Correct Answer: B. Decreased drug clearance and prolonged half-life.
🔵 Explanation: Reduced renal function decreases elimination of renally cleared
medications. This lowers clearance and generally increases the drug's elimination
half-life, potentially causing accumulation and toxicity unless the dose or dosing
interval is adjusted.
QUESTION 2
A patient taking warfarin begins therapy with trimethoprim-sulfamethoxazole for a
urinary tract infection. Several days later, the patient's INR is markedly elevated.
Which mechanism best explains this interaction?
A. Increased vitamin K synthesis by intestinal bacteria
B. Reduced anticoagulant absorption from the gastrointestinal tract
C. Increased warfarin effect through impaired metabolism and reduced vitamin K
availability
D. Competitive displacement of warfarin from hemoglobin
🔴 Correct Answer: C. Increased warfarin effect through impaired metabolism
and reduced vitamin K availability.
🔵 Explanation: Trimethoprim-sulfamethoxazole can significantly increase warfarin's
anticoagulant effect through CYP-mediated metabolic inhibition and reduction of
vitamin K-producing intestinal flora. Close INR monitoring and consideration of an
alternative antimicrobial are appropriate.
QUESTION 3
A patient with hypertension, type 2 diabetes, and albuminuria requires an
antihypertensive medication. Which pharmacologic strategy provides the greatest
renal-protective benefit?
,A. Initiate a thiazide diuretic as monotherapy
B. Initiate an ACE inhibitor and monitor renal function and potassium
C. Initiate a nondihydropyridine calcium channel blocker exclusively
D. Initiate a beta blocker as first-line renal protection
🔴 Correct Answer: B. Initiate an ACE inhibitor and monitor renal function and
potassium.
🔵 Explanation: ACE inhibitors reduce intraglomerular pressure and albuminuria and
provide kidney protection in appropriate patients with diabetes and albuminuria.
Serum creatinine and potassium should be monitored because ACE inhibition can
cause hyperkalemia and an initial rise in creatinine.
QUESTION 4
A patient receiving lisinopril develops facial swelling and difficulty breathing. Which
action should the nurse practitioner prioritize?
A. Administer the next dose with food
B. Discontinue lisinopril and provide urgent treatment for angioedema
C. Reduce the lisinopril dose by 50%
D. Add an antihistamine and continue lisinopril
🔴 Correct Answer: B. Discontinue lisinopril and provide urgent treatment for
angioedema.
🔵 Explanation: ACE inhibitor-associated angioedema can rapidly compromise the
airway and may occur even after prolonged therapy. The medication should be
discontinued permanently, and airway assessment and emergency management take
priority.
QUESTION 5
A patient with heart failure with reduced ejection fraction takes carvedilol. The
patient reports increased fatigue after the dose was titrated upward, but blood
pressure and heart rate remain clinically acceptable. Which principle should guide
management?
A. Immediately discontinue carvedilol
B. Double the dose to overcome tolerance
C. Assess volume status and tolerability while continuing evidence-based titration
, when appropriate
D. Substitute a short-acting beta agonist
🔴 Correct Answer: C. Assess volume status and tolerability while continuing
evidence-based titration when appropriate.
🔵 Explanation: Beta blockers such as carvedilol improve outcomes in appropriate
patients with HFrEF, but initiation and titration can temporarily worsen fatigue or
symptoms. Therapy should be individualized according to hemodynamics, volume
status, adverse effects, and clinical response.
QUESTION 6
A patient taking spironolactone for heart failure has a potassium level of 6.1 mEq/L.
Which action is most appropriate?
A. Continue therapy and increase dietary potassium
B. Administer an additional dose of spironolactone
C. Hold spironolactone and urgently evaluate and treat hyperkalemia
D. Add potassium chloride supplementation
🔴 Correct Answer: C. Hold spironolactone and urgently evaluate and treat
hyperkalemia.
🔵 Explanation: Spironolactone is a potassium-sparing aldosterone antagonist.
Significant hyperkalemia can produce life-threatening cardiac dysrhythmias. Therapy
should be held and the patient promptly evaluated for hyperkalemia management.
QUESTION 7
A patient with asthma uses albuterol several times each day despite adherence to
prescribed inhaled corticosteroid therapy. Which interpretation is most
appropriate?
A. Frequent rescue-inhaler use indicates adequate disease control
B. The patient should discontinue the inhaled corticosteroid
C. Persistent symptoms suggest inadequate control and warrant reassessment of
therapy and adherence
D. Albuterol should automatically be replaced with oral corticosteroids indefinitely
COMPREHENSIVE EXAM PRACTICE & ACTUAL STUDY GUIDE — 2026/2027
LATEST UPDATE | 120+ PRACTICE QUESTIONS, VERIFIED SOLUTIONS WITH
RATIONALES
TABLE OF CONTENTS
i. Pharmacokinetics, Pharmacodynamics, and Drug Interactions
ii. Cardiovascular and Renal Pharmacotherapy
iii. Endocrine and Metabolic Pharmacology
iv. Antimicrobial and Antiviral Therapy
v. Central Nervous System and Psychiatric Pharmacology
vi. Respiratory and Gastrointestinal Pharmacology
vii. Hematologic, Oncologic, and Immunologic Pharmacology
viii. Pain, Inflammation, and Rheumatologic Therapy
ix. Special Populations, Safety, Monitoring, and Medication Management
INTRODUCTION
This advanced NURS 6521 pharmacology practice exam focuses on graduate-level
application of pharmacokinetics, pharmacodynamics, therapeutic drug monitoring,
adverse effects, drug interactions, contraindications, antimicrobial therapy,
cardiovascular medications, endocrine agents, psychiatric drugs, analgesics, and
pharmacotherapy in special populations. Questions emphasize clinical reasoning
rather than simple recall, requiring interpretation of patient findings, laboratory
values, medication profiles, and therapeutic priorities. Students should expect
challenging scenarios involving adverse drug reactions, renal and hepatic
considerations, polypharmacy, medication selection, monitoring parameters, and
patient-specific risk factors. The questions are designed to reinforce the level of
clinical judgment expected in advanced nursing pharmacology coursework and
professional practice.
QUESTION 1
A 72-year-old patient with atrial fibrillation and chronic kidney disease is prescribed
a medication that is primarily eliminated through the kidneys. The patient's serum
,creatinine increases substantially after an episode of dehydration. Which
pharmacokinetic consequence is most likely?
A. Increased hepatic first-pass metabolism
B. Decreased drug clearance and prolonged half-life
C. Increased volume of distribution caused by reduced renal perfusion
D. Decreased plasma protein binding caused by dehydration
🔴 Correct Answer: B. Decreased drug clearance and prolonged half-life.
🔵 Explanation: Reduced renal function decreases elimination of renally cleared
medications. This lowers clearance and generally increases the drug's elimination
half-life, potentially causing accumulation and toxicity unless the dose or dosing
interval is adjusted.
QUESTION 2
A patient taking warfarin begins therapy with trimethoprim-sulfamethoxazole for a
urinary tract infection. Several days later, the patient's INR is markedly elevated.
Which mechanism best explains this interaction?
A. Increased vitamin K synthesis by intestinal bacteria
B. Reduced anticoagulant absorption from the gastrointestinal tract
C. Increased warfarin effect through impaired metabolism and reduced vitamin K
availability
D. Competitive displacement of warfarin from hemoglobin
🔴 Correct Answer: C. Increased warfarin effect through impaired metabolism
and reduced vitamin K availability.
🔵 Explanation: Trimethoprim-sulfamethoxazole can significantly increase warfarin's
anticoagulant effect through CYP-mediated metabolic inhibition and reduction of
vitamin K-producing intestinal flora. Close INR monitoring and consideration of an
alternative antimicrobial are appropriate.
QUESTION 3
A patient with hypertension, type 2 diabetes, and albuminuria requires an
antihypertensive medication. Which pharmacologic strategy provides the greatest
renal-protective benefit?
,A. Initiate a thiazide diuretic as monotherapy
B. Initiate an ACE inhibitor and monitor renal function and potassium
C. Initiate a nondihydropyridine calcium channel blocker exclusively
D. Initiate a beta blocker as first-line renal protection
🔴 Correct Answer: B. Initiate an ACE inhibitor and monitor renal function and
potassium.
🔵 Explanation: ACE inhibitors reduce intraglomerular pressure and albuminuria and
provide kidney protection in appropriate patients with diabetes and albuminuria.
Serum creatinine and potassium should be monitored because ACE inhibition can
cause hyperkalemia and an initial rise in creatinine.
QUESTION 4
A patient receiving lisinopril develops facial swelling and difficulty breathing. Which
action should the nurse practitioner prioritize?
A. Administer the next dose with food
B. Discontinue lisinopril and provide urgent treatment for angioedema
C. Reduce the lisinopril dose by 50%
D. Add an antihistamine and continue lisinopril
🔴 Correct Answer: B. Discontinue lisinopril and provide urgent treatment for
angioedema.
🔵 Explanation: ACE inhibitor-associated angioedema can rapidly compromise the
airway and may occur even after prolonged therapy. The medication should be
discontinued permanently, and airway assessment and emergency management take
priority.
QUESTION 5
A patient with heart failure with reduced ejection fraction takes carvedilol. The
patient reports increased fatigue after the dose was titrated upward, but blood
pressure and heart rate remain clinically acceptable. Which principle should guide
management?
A. Immediately discontinue carvedilol
B. Double the dose to overcome tolerance
C. Assess volume status and tolerability while continuing evidence-based titration
, when appropriate
D. Substitute a short-acting beta agonist
🔴 Correct Answer: C. Assess volume status and tolerability while continuing
evidence-based titration when appropriate.
🔵 Explanation: Beta blockers such as carvedilol improve outcomes in appropriate
patients with HFrEF, but initiation and titration can temporarily worsen fatigue or
symptoms. Therapy should be individualized according to hemodynamics, volume
status, adverse effects, and clinical response.
QUESTION 6
A patient taking spironolactone for heart failure has a potassium level of 6.1 mEq/L.
Which action is most appropriate?
A. Continue therapy and increase dietary potassium
B. Administer an additional dose of spironolactone
C. Hold spironolactone and urgently evaluate and treat hyperkalemia
D. Add potassium chloride supplementation
🔴 Correct Answer: C. Hold spironolactone and urgently evaluate and treat
hyperkalemia.
🔵 Explanation: Spironolactone is a potassium-sparing aldosterone antagonist.
Significant hyperkalemia can produce life-threatening cardiac dysrhythmias. Therapy
should be held and the patient promptly evaluated for hyperkalemia management.
QUESTION 7
A patient with asthma uses albuterol several times each day despite adherence to
prescribed inhaled corticosteroid therapy. Which interpretation is most
appropriate?
A. Frequent rescue-inhaler use indicates adequate disease control
B. The patient should discontinue the inhaled corticosteroid
C. Persistent symptoms suggest inadequate control and warrant reassessment of
therapy and adherence
D. Albuterol should automatically be replaced with oral corticosteroids indefinitely
